FDA Approves SimpleScreen CRC Blood Test for Average-Risk Adults

▪ SCREENING

The FDA has approved SimpleScreen CRC, a new blood-based screening option for colorectal cancer in adults aged 45 years and older who are at average risk, based on data from the PREEMPT CRC trial. (The ASCO Post)